BioAffinity awarded U.S.federal supply schedule contract for CyPath Lung

bioAffinity Technologies, announced that CyPath Lung, its noninvasive test to detect early-stage lung cancer, will be added to the U.S. Federal Supply Schedule, a procurement system that provides the Veterans Health Administration VHA and the Military Health System streamlined access to state-of-the-art healthcare products and services. The VHA, part of the U.S. Department of Veterans Affairs VA , serves 9.1M Veterans each year and is the largest integrated health care system in the country, providing care at 1,380 health care facilities, including 170 medical centers and 1,193 outpatient sites of care of varying complexity , VHA outpatient clinics Approximately 8,000 Veterans are diagnosed and treated for lung cancer annually, according to the VA.